These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidental prostatic carcinoma. A predictive role of neoangiogenesis and comparison with other prognostic factors. Volavsek M; Masera A; Ovcak Z Pathol Oncol Res; 2000; 6(3):191-6. PubMed ID: 11033459 [TBL] [Abstract][Full Text] [Related]
5. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Leon SP; Folkerth RD; Black PM Cancer; 1996 Jan; 77(2):362-72. PubMed ID: 8625246 [TBL] [Abstract][Full Text] [Related]
6. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Hall MC; Troncoso P; Pollack A; Zhau HY; Zagars GK; Chung LW; von Eschenbach AC Urology; 1994 Dec; 44(6):869-75. PubMed ID: 7527168 [TBL] [Abstract][Full Text] [Related]
7. Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment. Josefsson A; Wikström P; Granfors T; Egevad L; Karlberg L; Stattin P; Bergh A Eur Urol; 2005 Oct; 48(4):577-83. PubMed ID: 15990221 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma. Sheng H; Aoe M; Doihara H; Andou A; Shimizu N Acta Med Okayama; 2000 Jun; 54(3):119-26. PubMed ID: 10925736 [TBL] [Abstract][Full Text] [Related]
9. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Tretiakova M; Antic T; Binder D; Kocherginsky M; Liao C; Taxy JB; Oto A Hum Pathol; 2013 Apr; 44(4):495-502. PubMed ID: 23069258 [TBL] [Abstract][Full Text] [Related]
10. Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma. Brawer MK Cancer; 1996 Jul; 78(2):345-9. PubMed ID: 8674015 [TBL] [Abstract][Full Text] [Related]
11. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade. Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077 [TBL] [Abstract][Full Text] [Related]
12. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240 [TBL] [Abstract][Full Text] [Related]
13. Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis. Offersen BV; Borre M; Sørensen FB; Overgaard J APMIS; 2002 Feb; 110(2):177-85. PubMed ID: 12064874 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of vasohibin-1 expression in patients with prostate cancer. Kosaka T; Miyazaki Y; Miyajima A; Mikami S; Hayashi Y; Tanaka N; Nagata H; Kikuchi E; Nakagawa K; Okada Y; Sato Y; Oya M Br J Cancer; 2013 May; 108(10):2123-9. PubMed ID: 23591203 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. Bochner BH; Cote RJ; Weidner N; Groshen S; Chen SC; Skinner DG; Nichols PW J Natl Cancer Inst; 1995 Nov; 87(21):1603-12. PubMed ID: 7563203 [TBL] [Abstract][Full Text] [Related]
17. Independent prognostic importance of microvessel density in clinically localized prostate cancer. Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456 [TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155 [TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512 [TBL] [Abstract][Full Text] [Related]
20. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation. Vartanian RK; Weidner N Lab Invest; 1995 Dec; 73(6):844-50. PubMed ID: 8558846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]